Voyager Therapeutics

voyagertherapeutics.com

Voyager Therapeutics is a biotechnology company focused on leveraging human genetics to develop transformative medicines for neurological diseases. Their pipeline includes genetic therapies for Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease, utilizing their proprietary TRACER™ AAV capsid discovery platform to enhance delivery across the blood-brain barrier. The company aims to modify the course of these debilitating conditions and ultimately find cures, positioning itself as a leader in neurogenetic medicine with a strong commitment to innovation and patient care.